Who We Are

ABSINCGROUP is a premier strategic consulting providing top-tier regulatory, quality, and technical expertise to the biopharmaceutical, pharmaceutical, biotechnology, medical device, and diagnostics industries.

With a global team of senior professionals and former regulatory authorities, we specialize in end-to-end product lifecycle consulting, from R&D, Manufacturing to regulatory approval and post-market compliance. Our clients trust us to deliver FDA- and EMA-compliant results, on time and on budget.

How AI Enhances Strategic Regulatory Consulting

At ABSINCGROUP, we seamlessly integrate artificial intelligence (AI) throughout every phase of manufacturing, testing, regulatory, quality, and compliance consulting. Our AI-powered solutions transform traditional processes into intelligent, scalable and predictive systems that minimize risk and accelerate regulatory approvals.

Why Clients Choose ABSINCGROUP

Trusted by global leaders in biopharmaceutical innovation

35+ Years of Global Regulatory Expertise

Decades of proven experience in navigating complex regulatory landscapes worldwide

Multinational Team of Former FDA/EMA/WHO Experts

Expert consultants with insider knowledge from leading regulatory agencies

Track Record in Biologics, Biosimilars, and Therapeutics

Specialized expertise in cutting-edge biological product development

Agile Project Deployment & Remote Global Delivery

Flexible, efficient project execution across global markets

Strategic + Tactical Support from One Integrated Team

Comprehensive solutions from strategic planning to tactical implementation

AI-Driven Quality and Regulatory Transformation

AI-driven tools improve compliance, streamline submissions, and accelerate approvals.

Specialized Expertise in Biologics & Biosimilars

Our consultants are recognized experts in complex biopharmaceutical development

Biosimilar Development

Cell Line Qualification

Regulatory Writing

Clinical & CMC Data Strategy

Cell Gene Therapy

Biologics

Process Development, Methods Development, Manufacturing, Formulation, Fill Finish, and Regulatory Strategy

•

Biosimilar Development

R&D Through Commercial Launch Expertise

•

Cell Line and Seed Bank Qualification

Characterization and Optimization Services

•

Regulatory Writing

INDs, NDAs, eBLAs, ANDAs, 510(k), and Global Filings

•

Clinical and CMC Data Strategy

Complex Biologics Data Integrity and Management

•

Follow-on Biologics

Emerging Regulatory Pathways

•

Who We Serve

Supporting clients across the U.S., EU, MENA, and Asia-Pacific

Biopharma & Biotech

mAbs, Vaccines, CGT

Pharmaceuticals

Injectables, Solids, Semi-solids

Diagnostics & Medical Devices

Advanced Diagnostic Solutions

Biosimilars & Follow-on Biologics

Next-Generation Therapeutics

All Company Sizes

Startups to Global Enterprises